home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Why are we Seeing More Independent Data Safety Monitoring

 
  October 24, 2017  
     
 
Netzealous LLC DBA - Compliance4All, Online
2017-12-05


Overview:
It is important to see what the FDA regulations and the ICH GCP recommendations are in regard to DMC's. Most importantly, when does an adverse event (AE) or string of AE's lead to changes in a study protocol or even discontinuation of a study. 

Why should you Attend:
With the increasing requirements for a DMC oversight it behooves all involved to know the set-up and function of these committees. Forewarned is forearmed.

Areas Covered in the Session:
Studies requiring a formal Safety Monitoring Committee
What does the "Charter" of a DMC compose of?
What is the composition and function of a DMC?
What types of studies "require" a DMC?

Who Will Benefit:
Clinical Research Scientists
Research Managers
Safety Nurses
Clinical Research Associates (CRAs) 

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
 
 
Organized by: Event Manager
Invited Speakers:

Speaker Profile:
Charles H. Pierce MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects.
 
Deadline for Abstracts: 2017-12-04
 
Registration:

Full Details & Registration Link:

http://www.compliance4all.com/control/w_product/~product_id=501591LIVE?channel=molgen_Dec_2017_SEO 

E-mail: support@compliance4All.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.